Cargando…

Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers

The emergence of SARS-CoV-2 variants raised questions regarding the durability of immune responses after homologous or heterologous boosters after Ad26.COV2.S-priming. We found that SARS-CoV-2–specific binding antibodies, neutralizing antibodies, and T cells are detectable 5 months after boosting, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sablerolles, Roos S G, Rietdijk, Wim J R, Goorhuis, Abraham, Postma, Douwe F, Visser, Leo G, Schmitz, Katharina S, Geers, Daryl, Bogers, Susanne, van Haren, Eva, Koopmans, Marion P G, Dalm, Virgil A S H, Kootstra, Neeltje A, Huckriede, Anke L W, Akkerman, Renate, Beukema, Martin, Lafeber, Melvin, van Baarle, Debbie, de Vries, Rory D, van der Kuy, P Hugo M, GeurtsvanKessel, Corine H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384313/ https://www.ncbi.nlm.nih.gov/pubmed/35723273 http://dx.doi.org/10.1093/cid/ciac495

Ejemplares similares

Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol
por: Sablerolles, Roos S. G., et al.
Publicado: (2021)

Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol
por: Tan, Ngoc H., et al.
Publicado: (2022)

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
por: Sablerolles, Roos S.G., et al.
Publicado: (2022)

Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination
por: Geers, Daryl, et al.
Publicado: (2022)

Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial
por: Tan, Ngoc H, et al.
Publicado: (2023)

Evaluating novel COVID-19 vaccines in the current chapter of the pandemic
por: GeurtsvanKessel, Corine H, et al.
Publicado: (2022)

Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2022)

Complete Genome Characterization of Eight Human Parainfluenza Viruses from the Netherlands
por: Phan, My V. T., et al.
Publicado: (2019)

COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
por: Zaeck, Luca M, et al.
Publicado: (2023)

SARS-CoV-2–Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence
por: den Hartog, Gerco, et al.
Publicado: (2020)

Whole-Blood Testing for Diagnosis of Acute Zika Virus Infections in Routine Diagnostic Setting
por: Voermans, Jolanda J.C., et al.
Publicado: (2019)

Th(1)-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses
por: den Hartog, Yvette, et al.
Publicado: (2023)

Reply to: Comment on: Zika virus and Guillain–Barré syndrome in Bangladesh
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2018)

Understanding the association between sleep, shift work and COVID‐19 vaccine immune response efficacy: Protocol of the S‐CORE study
por: Lammers‐van der Holst, Heidi M., et al.
Publicado: (2021)

Street RABV Induces the Cholinergic Anti-inflammatory Pathway in Human Monocyte-Derived Macrophages by Binding to nAChr α7
por: Embregts, Carmen W. E., et al.
Publicado: (2021)

Shedding of Yellow Fever Virus From an Imported Case in the Netherlands After Travel to Brazil
por: Phan, My V T, et al.
Publicado: (2020)

Early IL-1 Signaling Promotes iBALT Induction after Influenza Virus Infection
por: Neyt, Katrijn, et al.
Publicado: (2016)

Tertiary lymphoid organs in infection and autoimmunity
por: Neyt, Katrijn, et al.
Publicado: (2012)

From more testing to smart testing: data-guided SARS-CoV-2 testing choices, the Netherlands, May to September 2020
por: van Beek, Janko, et al.
Publicado: (2022)

HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study
por: Hullegie, Sebastiaan J., et al.
Publicado: (2017)

Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity
por: van Leeuwen, Leanne P. M., et al.
Publicado: (2023)

Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study
por: Sablerolles, Roos S G, et al.
Publicado: (2021)

Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections
por: Langerak, Thomas, et al.
Publicado: (2021)

Rabies virus uniquely reprograms the transcriptome of human monocyte-derived macrophages
por: Embregts, Carmen W.E., et al.
Publicado: (2023)

Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories
por: van den Beld, Maaike J. C., et al.
Publicado: (2021)

Genomic sequence of yellow fever virus from a Dutch traveller returning from the Gambia-Senegal region, the Netherlands, November 2018
por: Phan, My VT, et al.
Publicado: (2019)

No association between use of angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID‐19 in the COvid MEdicaTion (COMET) study
por: Sablerolles, Roos S. G., et al.
Publicado: (2021)

Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
por: Sanders, Jan-Stephan F, et al.
Publicado: (2022)

COvid MEdicaTion (COMET) study: protocol for a cohort study
por: Sablerolles, Roos S G, et al.
Publicado: (2020)

Sewage surveillance system using urological wastewater: Key to COVID-19 monitoring?
por: de Jong, Florus C., et al.
Publicado: (2023)

Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised Person
por: Munnink, Bas B. Oude, et al.
Publicado: (2022)

The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients
por: Malahe, S. Reshwan K., et al.
Publicado: (2023)

Ongoing rabies outbreak in dogs of unprecedented scale and human cases in Nelson Mandela Bay Municipality, South Africa, up to 13 February 2022
por: Ravensberg, Matthijs F, et al.
Publicado: (2022)

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
por: Fendler, Annika, et al.
Publicado: (2022)

An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2020)

2939. Hepatitis A vaccine immunogenicity in an immunocompromised population: a prospective cohort study
por: Schnyder, Jenny, et al.
Publicado: (2023)

Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients
por: van Riel, Debby, et al.
Publicado: (2021)

Dried blood spot cards: A reliable sampling method to detect human antibodies against rabies virus
por: Doornekamp, Laura, et al.
Publicado: (2020)

Timing and sequence of vaccination against COVID-19 and influenza – Author's reply
por: Dulfer, Elisabeth A., et al.
Publicado: (2023)

mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
por: Oosting, Sjoukje F, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f3eelbga6ocps5ekrgfcf2jfig